AbbVie Inc., 10% Owner at REATA PHARMACEUTICALS INC (RETA), sold 450,000 shares at $22.50 ($10.1M) on 2017-03-28, disclosed to the SEC on 2017-03-30.
Open-market sale of $10.1M RETA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.